Octant Biotech
CA - EmeryvilleBiotechnology
Focus: Octant Biotech is a public-stage small molecule biotechnology company headquartered in Emeryville, CA, focused on ophthalmology drug development. The company operates at mid-cap scale with 501–1000 employees.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
5+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Octant Biotech?
AI assessmentOctant offers stability and focused therapeutic expertise for ophthalmology specialists, but limited pipeline depth and hiring suggest limited near-term advancement and business momentum.
Why Work Here
- Public company status provides equity liquidity and established governance structures absent in early-stage startups.
- Focused ophthalmology pipeline allows deep therapeutic expertise and potential for meaningful clinical impact in a large market.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Octant Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.